Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990
In Brief: Paul Sugarbaker to Head New DC Cancer Center; Michael Shimkin Dies; Tel Aviv Conference “Safe”
Broder Sworn In, Cites Three ‘Teachers’ – Gallo, Waldermann, DeVita
New Food Technology Could Lower Cancer Risk, Greenwald Says; Nutrition Lab Needed
Sullivan Confirmation Hearing Set For Feb. 1
USC Cancer Center Plans Expansion, Gets New Name
AACR Receives Record Number of Abstracts
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- Brown University reaches agreement with Trump administration to restore funding
- Harvey Risch, critic of COVID-19 response, tapped by White House to serve as chair of the President’s Cancer Panel
- Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
- John Byrd brings blood cancer expertise to solid tumor, immunology powerhouse at UPMC









